Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative study.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4521515)

Published in Open Heart on July 27, 2015

Authors

Emma Sandgren1, Cecilia Rorsman1, Johan Engdahl2, Nils Edvardsson3

Author Affiliations

1: Department of Medicine , Halland Hospital , Varberg , Sweden.
2: Department of Medicine , Halland Hospital , Halmstad , Sweden.
3: Sahlgrenska Academy , Sahlgrenska University Hospital , Göteborg , Sweden.

Articles cited by this

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36

A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med (1997) 10.02

Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol (2008) 4.63

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation (2004) 3.83

Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA (2013) 2.88

Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol (2011) 2.31

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol (2008) 2.10

A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J (2012) 1.91

Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project. BMJ (2009) 1.91

Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol (2006) 1.68

Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace (2008) 1.61

Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol (2003) 1.59

Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol (2004) 1.25

"Home monitoring" for early detection of implantable cardioverter-defibrillator failure: a single-center prospective observational study. Clin Res Cardiol (2008) 1.18

Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: appropriate programming. Circ Arrhythm Electrophysiol (2011) 1.08

Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart Rhythm (2005) 1.06

Programming ICDs in the Modern Era beyond Out-of-the Box Settings. Pacing Clin Electrophysiol (2011) 0.99

Clinical and economic impact of remote monitoring on the follow-up of patients with implantable electronic cardiovascular devices: an observational study. Telemed J E Health (2013) 0.93

Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. Int J Cardiol (2007) 0.91

Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II. Am J Cardiovasc Drugs (2009) 0.89

Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Pacing Clin Electrophysiol (2006) 0.89

Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy. Am J Cardiol (2005) 0.84

Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design. Europace (2011) 0.84

Optimal programming of implantable cardiac-defibrillators. Circulation (2013) 0.80

Home monitoring system improves the detection of ventricular arrhythmia and inappropriate shock. Chin Med J (Engl) (2012) 0.79

Phantom shock in a patient with an implantable cardioverter defibrillator: case report. Am J Crit Care (2003) 0.77

Reduction of the inappropriate ICD therapies by implementing a new fuzzy logic-based diagnostic algorithm. Ann Noninvasive Electrocardiol (2013) 0.77